Genetic testing company 23andMe (NASDAQ:ME) has filed for Chapter 11 bankruptcy protection in a Missouri federal court, marking a dramatic fall for a company once valued at nearly US$6 billion.

Genetic testing company 23andMe laid off 100 employees on Jan. 23 due to decreasing sales of its direct-to-consumer DNA test kits, CNBC reports. The layoffs, which affect about 14 percent of the ...

23andMe, which sold saliva collection kits to consumers wanting insight into their genetic background, filed for bankruptcy in March 2025. The company has now agreed to sell its data bank to Regeneron ...

When Anne Wojcicki was considering whether she should try to save her life’s work, genetic testing pioneer 23andMe, from ...

Anne Wojcicki is set to regain control of 23andMe after a $305 million bid from a nonprofit she controls topped Regeneron Pharmaceuticals’ offer for the DNA-testing company in a bankruptcy auction.

When we first wrote this article, it compared 23andMe and Ancestry. Since then, 23andMe has experienced a data breach, a subsequent lawsuit, board members' resignations and layoffs amidst financial ...

Genetic information company 23andMe has said that it is headed to bankruptcy court, raising questions for what happens to the DNA shared by millions of people with the company via saliva test kits.

Drugmaker Regeneron Pharmaceuticals will buy genetic testing firm 23andMe for $256 million through a bankruptcy auction, the companies said Monday. Regeneron said it will comply with 23andMe’s privacy ...

Capping off a dire run of bad news in the last year, 23andMe announced this week that it will be acquired by the pharmaceutical company, Regeneron. While this turn of events might not be the ...

Once a promising company briefly valued at $6 billion, 23andMe popularized at-home DNA test kits and spawned a cottage industry of ancestry hunters and true crime sleuths. But the company could not ...

'I'm tired of being the product' You're worth a fortune. I was sorry that 23andMe filed for Chapter 11 bankruptcy protection last week, but there would be a blizzard in Death Valley before I would ...

Bankrupt genetic-testing firm 23andMe agreed to sell its data bank, which once contained DNA samples from about 15 million people, to the drug developer Regeneron Pharmaceuticals for $256 million. The ...